Differences between blood-pressure-lowering drugs

Affiliations

Comment

S MacMahon et al. Lancet. 2000.

. 2000 Jul 29;356(9227):352-3.

doi: 10.1016/S0140-6736(00)02521-6.

No abstract available

Comment in

INSIGHT and NORDIL. International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment. Nordic Diltiazem Study.
Achard JM, Oudart N, Aldigier JC. Achard JM, et al. Lancet. 2000 Dec 2;356(9245):1926-7; author reply 1928-9. Lancet. 2000. PMID: 11130401 No abstract available.
INSIGHT and NORDIL. International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment. Nordic Diltiazem Study.
Fournier A, Georgita A, Bouffandeau B, Oprisiu R. Fournier A, et al. Lancet. 2000 Dec 2;356(9245):1927; author reply 1928-9. doi: 10.1016/s0140-6736(05)73476-0. Lancet. 2000. PMID: 11130405 No abstract available.

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.
Hansson L, Hedner T, Lund-Johansen P, Kjeldsen SE, Lindholm LH, Syvertsen JO, Lanke J, de Faire U, Dahlöf B, Karlberg BE. Hansson L, et al. Lancet. 2000 Jul 29;356(9227):359-65. doi: 10.1016/s0140-6736(00)02526-5. Lancet. 2000. PMID: 10972367 Clinical Trial.
Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
Brown MJ, Palmer CR, Castaigne A, de Leeuw PW, Mancia G, Rosenthal T, Ruilope LM. Brown MJ, et al. Lancet. 2000 Jul 29;356(9227):366-72. doi: 10.1016/S0140-6736(00)02527-7. Lancet. 2000. PMID: 10972368 Clinical Trial.